Gammanorm
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Gammanorm, covering 2018-09-05 to 2019-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push [Phase 4]